Immune · Reference
Thymosin Alpha-1 vs Thymalin: The Two Thymic Peptides Compared
This page explains each on its own terms, puts them side by side, covers what the research does and does not show, where each stands with the FDA, how each is dosed, what each costs at Pepti, and who tends to suit which.

Thymosin alpha-1 and thymalin are the two thymic immune peptides Pepti supplies, and they are not the same thing under two names. Thymosin alpha-1 is a single 28-amino-acid sequence, first isolated in the US in 1977 and now made synthetically, with randomized human trials over more than thirty years in hepatitis B, sepsis, melanoma and vaccine response, mixed results, and a branded version approved in some countries outside the US. Thymalin is a mixture of short peptides extracted from calf thymus, developed in Leningrad in the 1970s, with a long Russian observational programme in older adults and no randomized trials. Thymosin alpha-1 is the choice when the controlled-evidence file matters most; thymalin is the choice when the interest is specifically the Russian immune-ageing work. Both are prescription-only, compounded by a licensed US pharmacy, and neither is FDA approved.
This page explains each on its own terms, puts them side by side, covers what the research does and does not show, where each stands with the FDA, how each is dosed, what each costs at Pepti, and who tends to suit which.
Thymosin Alpha-1 vs Thymalin
The short answer
| If your main goal is | The usual prescription | What is in it | Price |
|---|---|---|---|
| Immune modulation with the deeper trial record | Thymosin Alpha-1 | 10 mg thymosin alpha-1 in a 5 mL vial (2 mg/mL); also a Pen | $249/mo |
| Immune ageing, following the Russian programme | Thymalin | 5 mg thymalin in a 5 mL vial (1 mg/mL) | $209/mo |
| Immune support plus gut and inflammation coverage | FORTIFY Blend | Thymosin alpha-1, BPC-157, KPV and LL-37 | $289/mo |
| The pineal half of the Russian ageing programme | Epithalon | 10 mg Epithalon in a 5 mL vial | $249/mo |
Every figure is an all-in monthly price covering the medication, physician review, refill management and shipping. There is no separate membership fee. Current pricing always lives on each product page.
Thymosin Alpha-1 vs Thymalin
Why these two get confused
Both trace back to the same idea from the 1970s: the thymus, where T cells mature, shrinks with age, so perhaps the signals it makes could be supplied from outside. In the United States, researchers fractionated calf thymus and isolated one specific peptide from a preparation called thymosin fraction 5; that became thymosin alpha-1. In Leningrad, a different group kept the whole extract and standardized it; that became thymalin. Same organ, same decade, two opposite approaches: one molecule versus a mixture.
Thymosin Alpha-1 vs Thymalin
Thymosin alpha-1 on its own terms
What it is
Thymosin alpha-1 is a 28-amino-acid peptide with an acetyl group on its N-terminus, cut by the body from a larger precursor called prothymosin alpha. Its generic name is thymalfasin. A synthetic branded version has been sold since the 1990s in a number of countries, principally in the Asia-Pacific region, Latin America, Eastern Europe and the Middle East, and in Italy, mainly for hepatitis B and as a vaccine adjuvant. It has never been approved by the FDA, and a compounded version carries none of those approvals. The full reference is at what is thymosin alpha-1.
How thymosin alpha-1 is described to work
- Dendritic cells and Toll-like receptors (TLR9 and TLR2), increasing cytokine production and antigen presentation, in mouse and cell work.
- T-cell maturation into CD4 and CD8 populations; a 2020 COVID-19 report measured circulating CD4 and CD8 T cells rising in treated patients.
- Natural killer cells and MHC class I, increased in cell and animal studies.
- A regulatory direction: a 2010 review called it "the regulator of regulators," describing a push toward regulatory T cells in mouse work.
What human data exists for thymosin alpha-1
Trial Who Result 1998, Hepatology 98 people with chronic hepatitis B Higher complete virological response at 18 months with treatment 2026 Cochrane review 10 trials, 1,349 people with hepatitis B May reduce mortality and serious adverse events; very low certainty 2012, Journal of Viral Hepatitis 552 people with hepatitis C No difference from placebo 2025, BMJ (TESTS) 1,106 adults with sepsis, double-blind No clear reduction in 28-day mortality 2010, Journal of Clinical Oncology 488 people with metastatic melanoma Survival signal short of significance There are no randomized trials of thymosin alpha-1 for immune support in otherwise healthy adults. Detail is in thymosin alpha-1 benefits.
Thymosin Alpha-1 vs Thymalin
Thymalin on its own terms
What it is
Thymalin is a polypeptide complex extracted from the thymus of young cattle, developed by Vladimir Khavinson and Vyacheslav Morozov from 1973 onward at what became the St. Petersburg Institute of Bioregulation and Gerontology. Its developers describe two dipeptides inside the mixture, Lys-Glu (KE) and Glu-Trp (EW), as the active components. It has been used clinically in Russia for decades. The full reference is at what is thymalin.
How thymalin is described to work
- T-cell maturation. A 2020 cell study reported human blood stem cells exposed to thymalin shifting toward a mature T-cell marker, CD28, which rose nearly seven times.
- Inflammatory cytokines. A 2023 paper reported thymalin and its dipeptides reducing IL-1 beta, IL-6 and TNF-alpha by 1.4 to 6 times in stimulated human immune cells; a 2022 study in a monocyte line reported reduced TNF and IL-6.
What human data exists for thymalin
Study Who What was reported 2002 and 2003 266 older adults over six to eight years, courses repeated annually 2.0 to 2.4-fold fewer acute respiratory illnesses; mortality 2.0 to 2.1 times lower than controls 2021, Stem Cell Reviews and Reports COVID-19 hospital patients Faster fall in IL-6, C-reactive protein and D-dimer 2022, Advances in Gerontology Severe COVID-19, middle-aged and elderly Better blood counts and clotting markers; lower in-hospital mortality None of the abstracts describes randomization, blinding or placebo, group sizes are not given for the hospital studies, and the work has not been independently replicated. There are no randomized controlled trials of thymalin. Detail is in thymalin benefits.
Thymosin Alpha-1 vs Thymalin
Head to head
| Thymosin alpha-1 | Thymalin | |
|---|---|---|
| What it is | One defined synthetic sequence, 28 amino acids | A natural extract of many short peptides |
| Source | Synthetic | Calf thymus |
| First described | 1977, United States | 1970s, Leningrad |
| Described active part | The whole peptide | Two dipeptides, Lys-Glu and Glu-Trp |
| Main described action | Dendritic cells, T cells, NK cells; modulator | T-cell maturation; lower inflammatory cytokines |
| Human evidence | Randomized trials over thirty years, several disease areas | Russian observational and hospital reports |
| Randomized trials | Yes; none in healthy adults | None |
| Largest study | 1,106-person sepsis trial, negative | 266-person observational programme |
| Approval anywhere | Branded version in some countries outside the US | Not approved in the United States; used clinically in Russia for decades |
| Allergy consideration | Single synthetic sequence | Animal-origin extract: theoretical allergy risk |
| FDA history | Category 2, removed 2024; committee voted 4 to 17 against | Never nominated |
| Vial at Pepti | 5 mL, 2 mg/mL (10 mg) | 5 mL, 1 mg/mL (5 mg) |
| Standard directions | 0.25 mL (25 units) once daily, Monday to Friday | 0.25 mL (25 units) once daily, Monday to Friday |
| Per dose | 0.5 mg | 0.25 mg |
| Doses per vial | 20, about 4 weeks | 20, about 4 weeks |
| Formats | Vial or Pen | Vial only |
| Price at Pepti | $249 a month | $209 a month |
| Blends | FORTIFY | None |
The real difference is the kind of evidence
Both are described around T-cell function, so the mechanism story overlaps. The difference is what stands behind each. Thymosin alpha-1 has controlled trials, and the trials are honest about it: some signals, some negatives, nothing in healthy people. Thymalin has decades of clinical use and long-term follow-up in older adults, but without the controls that would separate the peptide from differences between the groups. A physician choosing between them is choosing between two kinds of evidence, not two doses of the same thing. No study has compared them.
Thymosin Alpha-1 vs Thymalin
Who suits which
Thymosin alpha-1 first
For most people asking about thymic peptides, thymosin alpha-1 is the usual starting point because it is one defined molecule with the controlled-trial file, the published negative results included. It is also available as a pre-filled Pen and inside the FORTIFY Blend when gut and inflammation are part of the picture.
Thymalin
Thymalin suits someone specifically interested in the Russian immune-ageing programme and the whole-extract approach, who accepts that the human evidence is observational and is comfortable with an animal-derived product. Because the programme studied thymalin alongside the pineal extract Epithalamin, prescribers who use it often discuss Epithalon too; see Epithalon benefits.
Can you take thymosin alpha-1 and thymalin together?
The live thymalin reference notes that the two thymic peptides are not usually combined, because they are aimed at the same system. No study has tested them together. Your physician works out what fits after reviewing your intake.
Thymosin Alpha-1 vs Thymalin
When neither is the right first step
| Situation | What makes more sense |
|---|---|
| A diagnosed infection such as hepatitis B or C, or HIV | FDA-approved treatments, which have far stronger evidence |
| A diagnosed immunodeficiency | A specialist; neither replaces its established therapies |
| Inflammation rather than a weakened response | KPV, described around inflammatory signalling |
| Fatigue without an immune finding | A work-up for ordinary causes; see peptides for energy and fatigue |
| A physical injury | BPC-157 or TB-500 |
Thymosin Alpha-1 vs Thymalin
Where each stands with the FDA
| Thymosin alpha-1 | Thymalin | |
|---|---|---|
| Nomination | Nominated; placed in Category 2 in 2023 | Never nominated for the 503A bulks list |
| 2024 | Nomination withdrawn; removed from Category 2 effective 27 September | Not involved |
| Advisory committee | 4 December 2024: voted 4 to 17 against adding it to the Bulks List | Never reviewed |
| April 2026 Category 2 removals | Not involved; it had already left | Not involved; it was never there |
| Final determination | None issued | None; the FDA has expressed no view |
The FDA's 2024 briefing on thymosin alpha-1 cited incomplete physicochemical characterization, insufficient safety information including immunogenicity risk, and a lack of effectiveness evidence for the conditions evaluated. The "thymulin acetate" entry on the FDA's list is a different thymic peptide from thymalin. Both remain legal to prescribe as compounded medications, and compounded medications are not FDA approved. See are peptides FDA approved.
Thymosin Alpha-1 vs Thymalin
Dosing, side by side
Both carry the same printed direction at Pepti: 0.25 mL, which is 25 units on a U-100 insulin syringe, under the skin into the abdomen or thigh, once daily Monday through Friday. Because the vials differ in strength, that volume holds 0.5 mg of thymosin alpha-1 (2 mg/mL) or 0.25 mg of thymalin (1 mg/mL). The two figures are not comparable as "stronger" or "weaker," because the products are different substances. The branded thymosin alpha-1 schedule abroad, 1.6 mg twice weekly, is not the compounded direction. Your physician sets your directions after reviewing your intake, and they are printed on the vial; see thymosin alpha-1 dosage.
Twenty doses per vial covers about four weeks, so refills run every 28 days, one vial per fill. Both ship refrigerated with ice packs, ready to use, with sterile syringes and alcohol prep pads.
Thymosin Alpha-1 vs Thymalin
Side effects
Thymosin alpha-1. Randomized trials, including the 1,106-patient sepsis trial, report adverse-event rates similar to placebo. What is reported is mostly injection-site redness, mild soreness or bruising. The FDA raised immunogenicity from impure compounded material, which is a manufacturing-quality question. More is in thymosin alpha-1 side effects.
Thymalin. The Russian clinical reports do not describe a characteristic toxicity. What is reported is mostly injection-site redness, soreness, occasional bruising or itching. As an animal-derived extract it carries a theoretical allergy risk, so rash, hives or swelling beyond the injection site should be reported to your care team promptly.
For both, there is no established interaction list. Immunosuppressants, biologics and autoimmune disease belong on the intake. Facial or throat swelling or difficulty breathing needs emergency care first (call 911), then tell your physician.
Thymosin Alpha-1 vs Thymalin
Who should not take either, or should discuss it first
| Situation | Why |
|---|---|
| Pregnancy or breastfeeding | Not used; safety data is absent |
| Autoimmune disease or immunosuppressive therapy | Both act on immune signalling; raise it at intake |
| Known allergy to animal-derived products | Especially for thymalin |
| Tested athletes | Thymosin alpha-1 is not named on the 2026 WADA list but S0 applies; check the current list for either |
Thymosin Alpha-1 vs Thymalin
What the evidence shows, honestly
Thymosin alpha-1 is the better-documented of the two by a wide margin, and its documentation includes a large negative trial and no trials in healthy adults. Thymalin has a longer clinical tradition than most compounded peptides and striking numbers from an uncontrolled design that has never been tested in a randomized trial. Neither has been shown to strengthen immunity in otherwise healthy people. Any source describing either as proven for immune support is overstating it.
Thymosin Alpha-1 vs Thymalin
Where to get thymosin alpha-1 or thymalin prescribed
Neither can be bought legitimately without a prescription. Sites selling them "for research use only" are not accountable for identity, purity, sterility or concentration. The prescription route:
- Complete a free online intake covering your history, medications and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A pharmacy compounds it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with your directions printed on the vial.
- Your physician stays reachable for questions and side effects.
Pepti prescribes both in every state except Oklahoma, plus DC, and is cash-pay with no insurance billing. Step-by-step pages: how to get thymosin alpha-1 prescribed online and how to get thymalin prescribed online. The wider picture is in peptides for immune support.
References
What this is based on.
References
- Khavinson VKh, Morozov VG. [Geroprotective effect of thymalin and epithalamin] · Adv Gerontol (2002) · PMID 12577695
- Khavinson VKh. Peptides and Ageing · Neuro Endocrinol Lett (2002) · PMID 12374906
- Khavinson VK, Linkova NS, Kvetnoy IM, Polyakova VO, Drobintseva AO, Kvetnaia TV, Ivko OM. Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells · Bull Exp Biol Med (2020) · PMID 33237528
- Khavinson VK, Kuznik BI, Trofimova SV, Volchkov VA, Rukavishnikova SA, Titova ON, Akhmedov TA, Trofimov AV, Potemkin VV, Magen E. Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19 · Stem Cell Rev Rep (2021) · PMID 33575961
- Kuznik BI, Shapovalov KG, Smolyakov YN, Lukyanov SA, Tereshkov PP, Kazantseva LS, Linkova NS. [Morphological compound and indicators of the blood clotting system in severe COVID-19 patients of middle aged and elderly during treatment of Tocilizumab and Thymalin] · Adv Gerontol (2022) · PMID 36169363
- Avolio F, Martinotti S, Khavinson VK, Esposito JE, Giambuzzi G, Marino A, Mironova E, Pulcini R, Robuffo I, Bologna G, Simeone P, Lanuti P, Guarnieri S, Trofimova S, Procopio AD, Toniato E. Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line · Int J Mol Sci (2022) · PMID 35408963
- Linkova N, Khavinson V, Diatlova A, Petukhov M, Vladimirova E, Sukhareva M, Ilina A. The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19 · Int J Mol Sci (2023) · PMID 37686182
- Dominari A, Hathaway Iii D, Pandav K et al.. Thymosin alpha 1: A comprehensive review of the literature · World J Virol (2020) · PMID 33362999
- Pierluigi B, D'Angelo C, Fallarino F et al.. Thymosin alpha1: the regulator of regulators? · Ann N Y Acad Sci (2010) · PMID 20536444
- Wu J et al.. The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial · BMJ (2025) · PMID 39814420
- Wu J et al.. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial · Crit Care (2013) · PMID 23327199
- Naing C et al.. Thymosin-ɑ1 for people with chronic hepatitis B · Cochrane Database Syst Rev (2026) · PMID 42713852
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
Thymosin Alpha-1 vs Thymalin, answered.
No. Thymosin alpha-1 is a single synthetic 28-amino-acid sequence. Thymalin is an extract of many short peptides from calf thymus. Both came out of 1970s thymus research, on different continents.
Thymosin alpha-1 has the stronger controlled evidence: randomized trials over thirty years, with mixed results. Thymalin has Russian observational reports and no randomized trials. No study has compared them directly.
Neither has been tested for immune support in healthy adults. If depth of human evidence is what matters to you, thymosin alpha-1 has more. Thymalin is discussed specifically for immune ageing.
No. Thymulin is a different thymic nonapeptide that appears on the FDA's nominations list; thymalin has never been nominated.
They are not usually combined, because both target the same system. No study has tested the pair. Your physician works out what fits after reviewing your intake.
Both mostly cause injection-site reactions. Thymosin alpha-1 trials report adverse events similar to placebo. Thymalin, as an animal extract, carries a theoretical allergy risk.
Yes. Thymalfasin is its generic name. A compounded version is not the branded product and carries none of its foreign approvals.
The two are different substances from different sources at different vial strengths. At Pepti, thymalin is $209 a month and thymosin alpha-1 is $249 a month, all-in, including medication, physician review, refill management and shipping.
Thymosin alpha-1 is available as a vial or a pre-filled Pen cartridge. Thymalin is a vial and syringe only.
No. Compounded medications are not FDA approved. Thymosin alpha-1 received a 4 to 17 advisory committee vote against the Bulks List in 2024; thymalin has never been nominated. Neither has a final FDA determination.
No. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.


